Baudax Bio Inc (BXRX) is higher by Monday morning, with the stock gaining 5.13% in pre-market trading to 1.23.
BXRX's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 81 out of 146 industries, BXRX ranks higher than 1% of stocks.
Baudax Bio Inc has risen 3.54% over the past month, closing at $1.09 on December 14. During this period of time, the stock fell as low as $0.97 and as high as $1.19. BXRX has an average analyst recommendation of Strong Buy. The company has an average price target of $9.67.
Baudax Bio Inc has a Long-Term Technical rank of 2. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 98% of the market scoring higher. In the Biotechnology industry which is number 100 by this metric, BXRX ranks better than 6% of stocks.
Important Dates for Investors in BXRX:
-Baudax Bio Inc is set to release earnings on 2/11/2021. During their last earnings release the company posted EPS of $-5.83. -We do not have a set dividend date for Baudax Bio Inc at this time. Click Here to get the full Stock Score Report on Baudax Bio Inc (BXRX) Stock.
